Sun Genomics gathers $9.25m Series A

Sun Genomics, a direct-to-consumer custom probiotics and gut health company, has raised $9.25 million in Series A funding.

Sun Genomics, a direct-to-consumer custom probiotics and gut health company, has raised $9.25 million in Series A funding. Pangaea Ventures led the round.

Source: Press Release